Estimate impact of high-risk COVID populationBackgroundAs expected, on August 12, the U.S. Food and Drug Administration (FDA) authorized a booster dose of the COVID-19 mRNA vaccines for people with weakened immune systems. Multiple media reports gave no guidance at this time for people who had Johnson & Johnson's single-shot COVID-19 vaccination.
Confidio is a Maryland-based cloud platform that offers solutions such as pharmacy benefit procurement, consulting, audit, and analytics for employers and brokers.